Aznar J - Search Results

1

[PSA:alpha 1-antichymotrypsin ratio/total PSA in the diagnosis of prostatic cancer in the range of total PSA from 4 to 10 ng/ml].

Martínez Sarmiento M, España F, Royo M, Estellés A, Aznar J, Vera Donoso CD, Medina P, Jiménez Cruz JF. Martínez Sarmiento M, et al. Among authors: aznar j. Actas Urol Esp. 2001 Apr;25(4):269-77. doi: 10.1016/s0210-4806(01)72614-9. Actas Urol Esp. 2001. PMID: 11455828 Spanish.

2

Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia.

España F, Martínez M, Royo M, Vera CD, Estellés A, Aznar J, Jiménez-Cruz JF. España F, et al. Among authors: aznar j. Eur Urol. 1997;32(3):268-72. Eur Urol. 1997. PMID: 9358211

3

Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples.

España F, Royo M, Martínez M, Enguídanos MJ, Vera CD, Estellés A, Aznar J, Jiménez-Cruz JF, Heeb MJ. España F, et al. Among authors: aznar j. J Urol. 1998 Dec;160(6 Pt 1):2081-8. doi: 10.1097/00005392-199812010-00038. J Urol. 1998. PMID: 9817329

4

Longitudinal evaluation of the complexed-to-total prostate specific antigen ratio in men with prostate disease. Effect of treatment.

España F, Martínez M, Royo M, Vera CD, Estellés A, Aznar J, Jiménez-Cruz JF. España F, et al. Among authors: aznar j. Eur J Cancer. 1998 Aug;34(9):1375-80. doi: 10.1016/s0959-8049(98)00078-1. Eur J Cancer. 1998. PMID: 9849420

5

Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer.

Martínez M, España F, Royo M, Vera CD, Estellés A, Jiménez-Cruz JF, Medina P, Aznar J. Martínez M, et al. Among authors: aznar j. Eur Urol. 2000 Jul;38(1):85-90. doi: 10.1159/000020257. Eur Urol. 2000. PMID: 10859447

6

[Factors affecting the PSA:alpha 1 antichymotrypsin/total PSA ratio].

Martínez Sarmiento M, España F, Royo M, Estellés A, Aznar J, Peinado F, Alapont JM, Vera Donoso CD, Jiménez Cruz JF. Martínez Sarmiento M, et al. Among authors: aznar j. Actas Urol Esp. 2001 May;25(5):350-6. doi: 10.1016/s0210-4806(01)72630-7. Actas Urol Esp. 2001. PMID: 11512259 Spanish.

7

Changes in molecular forms of prostate-specific antigen during treatment with finasteride.

España F, Martínez M, Royo M, Estellés A, Alapont JM, Navarro S, Aznar J, Jiménez-Cruz JF. España F, et al. Among authors: aznar j. BJU Int. 2002 Nov;90(7):672-7. doi: 10.1046/j.1464-410x.2002.03002.x. BJU Int. 2002. PMID: 12410745 Clinical Trial.

8

Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.

España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. España F, et al. Among authors: aznar j. Thromb Res. 1991 Nov 1;64(3):309-20. doi: 10.1016/0049-3848(91)90002-e. Thromb Res. 1991. PMID: 1725227

9

Determination of total, free and complexed protein S in plasma by ELISA, and comparison with a standard electroimmunoassay.

España F, Hendl S, Aznar J, Gilabert J, Estellés A. España F, et al. Among authors: aznar j. Thromb Res. 1991 Jun 15;62(6):615-24. doi: 10.1016/0049-3848(91)90366-5. Thromb Res. 1991. PMID: 1833853

10

Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.

España F, Estelles A, Griffin JH, Aznar J. España F, et al. Among authors: aznar j. Thromb Haemost. 1991 Jan 23;65(1):46-51. Thromb Haemost. 1991. PMID: 1850876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters